Skip to main content
Caplight Logo









Rocapine

Rocapine

Private
ParisHealthcare & Life Scienceshttps://rocapi.ne

Last Round

Series A

Jun 16, 2026

Total Funding Raised

$13M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Rocapine operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Series A round in June 2026.

Rocapine is a digital health and wellness company that develops and publishes mobile applications intended to support mental and physical wellbeing.

Sector

Healthcare & Life Sciences

Verticals

Sports & Fitness, Mental Health, Digital Publishing, Subscription Commerce

Business Model

B2C

Customer Profile

Subscription SaaS, Revenue Share, Freemium

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Rocapine Comparables

Compare Rocapine with similar companies based on industry and business-model similarity.

Rocapine comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Luni
76%
XTECH AI TECHNOLOGY JOINT STOCK COMPANY
68%
Enerjoy
68%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Rocapine Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 16, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Rocapine Investors

Notable investors and investment history

Rocapine investors
InvestorRounds
Athletico VenturesSeries A
DaphniSeries A, VC Round
Better AngleSeries A
EduCapitalSeries A
Ring CapitalSeries A
Centre Court CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 16, 2026

    $13M round with participation from Athletico Ventures and Better Angle.

Book a demo to see all signals

For institutional investors. Book with your work email.

Rocapine Filings

Explore SEC and related filing metadata, where available.

Rocapine filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Rocapine's valuation, stock price, and market status.

Is Rocapine a public or private company?

Rocapine is a private company.

What is the current stock price of Rocapine?

Rocapine is a private company, so its shares have no public market price. Caplight tracks Rocapine's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Rocapine worth (valuation)?

Valuation information for Rocapine is not publicly available.

Can I buy Rocapine stock?

Rocapine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Rocapine's last funding round?

Rocapine's most recent funding round was Series A on June 16, 2026.

Who are the main investors in Rocapine?

Key investors in Rocapine include Daphni, EduCapital.

Will Rocapine IPO soon?

No public IPO plans have been announced for Rocapine.

How can I track Rocapine secondary market activity?

Caplight tracks bids, offers, and trades in Rocapine's shares on secondary markets.

Firmographic Details

HeadquartersParis
Year Founded2024
Last FundingJun 16, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?